The results indicated that XLLXF may play an anti-TNBC role, mainly through cancer-related pathways, PI3K/Akt signaling pathways, TNF signaling pathways, HIF-1 signaling pathways, MAPK signaling pathways, and VEGF signaling pathways (Fig. 3d). Here, TNF is linked to cancer.